Jobs / United States / Glaxosmithkline LLC
Scientific Director, Infectious Disease
Glaxosmithkline LLC · 🇺🇸 2 Locations
Sponsorship verdict
Sponsorship possible
One solid signal, not two — worth applying, and worth asking about sponsorship early.
- Employer is on a government sponsor recordThe US Department of Labor certified 39 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 15 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
- The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
- No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- What Glaxosmithkline LLC paid sponsored hires in similar roles2 certified filings for “Associate Director/Scientific Leader, PDI” (Molecular and Cellular Biologists) in MA: $157k–$157k, median $157k. Most were filed at wage level II (50%) — 2 lottery entries, ≈31% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
- Confirmed live todayWhen a source last listed this job as open.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.
Or apply yourself on the official page →
Sponsor Radar — Glaxosmithkline LLC
The US Department of Labor certified 39 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 15 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Glaxosmithkline LLC →
About the role
We create a place where people can grow, be their best, be safe, and feel welcome, valued and included. We offer a competitive salary, an annual bonus based on company performance, healthcare and wellbeing programmes, pension plan membership, and shares and savings programme. We embrace modern work practises; our Performance with Choice programme offers a hybrid working model, empowering you to find the optimal balance between remote and in-office work. Discover more about our company wide benefits and life at GSK on our webpage Life at GSK | GSK Scientific Director , Infectious Disease GSK is a science-led global healthcare company that unites science, technology and talent to deliver innovative medicines, vaccines and specialty care. Within GSK, the Vaccine and Infectious Disease Research Unit (VIDRU) brings together immunology, pathogen biology and translational science, while Infectious Disease Research (IDR) advances innovative medicines to prevent, treat and cure priority infectious diseases. The Scientific Director will lead strategic and technical work across infectious disease drug discovery programmes, with a particular focus on innovative large-molecule therapies and monoclonal antibody-based modalities (monoclonal antibodies, bi-specifics, antibody-drug conjugates, new antibody formats such as scFv and delivery technologies). The role requires strong experience spanning discovery through early clinical development, translating scientific insight into programme strategy and driving assets towards robust investment, go/no-go decisions. Operating with significant independence and visibility, the Scientific Director will set scientific and project direction, lead multidisciplinary matrix teams and represent the work with senior leaders, regulators, auditors, external partners and key opinion leaders. The role is accountable for strategy, resources and high-quality evidence across multiple assets, influencing effectively across R&D and potentially managing lab-based scientists as the organisation evolves. For candidates seeking to be located at our Stevenage site, this role will temporarily be based at Stevenage. However, the Company plans to relocate its offices to Cambridge, UK. The location of this role will therefore subsequently change to Cambridge, UK in accordance with timelines to be set by the Company. The relocation is currently proposed to take effect by early 2029. Key Accountabilities / Responsibilities: • Lead multidisciplinary, cross-functional teams to define and deliver medicine and project strategies across infectious disease discovery and early development, aligned with business objectives. • Take accountability for high-quality scientific data packages supporting regulatory submissions, clinical protocols, patents, grants and relevant tax deductions. • Drive candidate progression by integrating scientific evidence, risk, resources, budgets and timelines, making clear recommendations at key portfolio decision points. • Provide strategic and technical leadership, maintaining sufficient scientific depth to challenge assumptions, guide research direction and ensure project quality. • Develop and maintain robust project plans, proactively managing risks, issues, dependencies and mitigation actions to deliver on time, within budget and to required standards. • Build strong relationships and communicate progress effectively with internal partners, senior leaders, governance and regulatory stakeholders, scientific forums and external experts. • Ensure programmes comply with GSK policies, procedures, HSE expectations and regulatory requirements, while establishing external collaborations and technology partnerships that strengthen scientific excellence and innovation. • Contribute to the g